Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

A new study suggests that people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) may live longer ...

Chronic lymphocytic leukemia (CLL) remains an incurable disease ... leukostasis is rare because of the characteristics and surface of CLL cells, which are very small in contrast to other lymphoma ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib received approval from the China National Medical Products ...

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...

In a review of 182 cancer studies, authors failed to report outcome data by sex in 90% of cases, even though men develop ...

Limited’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were taking cholesterol-lowering statin ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the ...